SCHEMBL6174619

SCHEMBL6174619

CC(c1ccnc2ccc(Cl)cc12)C1(C(C)c2ccnc3ccc(Cl)cc23)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.43
CNR1 P21554 2/20 0.38
THRB P10828 1/20 0.36
MAPT P10636 1/20 0.36
AR P10275 4/20 0.35
CYP2C9 P11712 2/20 0.35
KMT2A Q03164 2/20 0.33
LMNA P02545 3/20 0.33
GAA P10253 1/20 0.33
TP53 P04637 2/20 0.31
TAAR1 Q96RJ0 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
PGR P06401 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
ALOX12 P18054 1/20 0.31
NFKB1 P19838 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171792 0.90 IGF1R (0.44) IGF1RCNR1ARCYP2C9KMT2A
SCHEMBL6173145 0.90 IGF1R (0.43) IGF1RCNR1ARCYP2C9KMT2A
SCHEMBL6174593 0.88 IGF1R (0.42) IGF1RTHRBMAPTARCYP2C9
SCHEMBL6172835 0.88 IGF1R (0.42) IGF1RCNR1THRBMAPTAR
SCHEMBL6174623 0.88 IGF1R (0.42) IGF1RCNR1ARCYP2C9KMT2A
SCHEMBL6176261 0.85 DDR1 (0.38) MAPTARCYP3A4
SCHEMBL6176113 0.85 IGF1R (0.42) IGF1RARCYP2C9KMT2ALMNA
SCHEMBL6172572 0.83 IGF1R (0.41) IGF1RARCYP2C9KMT2ALMNA
SCHEMBL6173870 0.82 IGF1R (0.43) IGF1RTHRBMAPTARCYP2C9
SCHEMBL6171829 0.82 IGF1R (0.42) IGF1RTHRBMAPTARCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed